Ajanta Pharma Profit & Loss Annual

BSE: 532331 | NSE: AJANTPHARM | ISIN: INE031B01049 | Sector: Biotechnology & Drugs

3,407.00 -30.25 (-0.88%)Updated : 09 Oct 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	4,126.26	3,519.64	3,156.08	3,062.04
Other Net	13.05	4.14	3.59	6.15
Diluted Weighted Average Shares	12.50	12.52	12.60	12.81
Gain( Loss)on Saleof Assets	-1.87	-0.60	-3.49	-6.19
Depreciation/ Amortization	173.14	144.11	135.40	130.31
Operating Income	1,326.60	1,128.46	1,052.63	680.60
Net Income	1,056.00	920.39	816.17	587.98
Income Availableto Com Excl Extra Ord	1,056.00	920.39	816.17	587.98
Other Operating Expenses Total	72.61	62.17	46.95	40.13
Net Income Before Taxes	1,377.65	1,189.16	1,113.93	745.25
Net Income After Taxes	1,056.00	920.39	816.17	587.98
Income Availableto Com Incl Extra Ord	1,056.00	920.39	816.17	587.98
Costof Revenue Total	1,254.47	1,127.15	1,115.32	1,116.73
Gross Profit	4,198.39	3,520.95	3,093.39	2,625.91
Interest Inc( Exp) Net- Non- Op Total	39.87	57.16	61.20	64.69
Diluted Net Income	1,056.00	920.39	816.17	587.98
DPS- Common Stock Primary Issue	28.00	28.00	10.00	7.00
Provisionfor Income Taxes	321.65	268.77	297.76	157.27
period Type	-	-	-	-
Net Income Before Extra Items	1,056.00	920.39	816.17	587.98
Total Revenue	5,452.86	4,648.10	4,208.71	3,742.64
period Length	12.00	12.00	12.00	12.00
Revenue	5,452.86	4,648.10	4,208.71	3,742.64
Selling/ General/ Admin Expenses Total	2,626.04	2,186.21	1,858.41	1,774.38
Diluted Normalized EPS	84.63	73.56	64.97	46.27
Diluted EPS Excluding Extra Ord Items	84.51	73.53	64.77	45.89
Interest Exp( Inc) Net- Operating Total	-	-	0.00	0.49

*All figures in crores except per share values

Trending Stocks

1,035.00+40.00(4.02%)

2,079.30+29.30(1.43%)

1,246.00+17.00(1.38%)

11,400.00-549.00 (-4.59%)

2,851.05-96.35 (-3.27%)

Related News